ETF Holdings Breakdown of ALT

Stock Name	Altitude Group Plc
Ticker	ALT(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB00B0LSFV82
LEI	213800VACSTYYSI39R89

News associated with ALT

Altimmune, Inc. (NASDAQ:ALT) Shares Acquired by MetLife Investment Management LLC: MetLife Investment Management LLC increased its stake in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) by 7.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 44,474 shares of the company’s stock after purchasing an additional 2,897 shares during the period. MetLife Investment Management LLC’s holdings in Altimmune were worth $321,000 as of […] - 2025-05-08 08:02:49
Barclays PLC Grows Position in Altimmune, Inc. (NASDAQ:ALT): Barclays PLC lifted its position in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) by 1.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 157,528 shares of the company’s stock after purchasing an additional 1,787 shares during the quarter. Barclays PLC’s holdings in Altimmune were worth […] - 2025-05-05 07:48:49
Noteworthy Friday Option Activity: ALT, DUOL, AMD: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Altimmune Inc (Symbol: ALT), where a total of 15,292 contracts have traded so far, representing approximately 1.5 million underlying shares. That amounts to about 74.3% - 2025-05-02 19:22:38
Legal & General Group Plc Lowers Position in Altimmune, Inc. (NASDAQ:ALT): Legal & General Group Plc decreased its stake in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 8.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 68,102 shares of the company’s stock after selling 6,046 shares during the period. Legal & General Group Plc’s holdings in Altimmune were worth $491,000 as of its most […] - 2025-04-30 08:30:58
Schroder Investment Management Group Has $3.14 Million Stock Position in Altimmune, Inc. (NASDAQ:ALT): Schroder Investment Management Group lessened its position in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 9.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 428,321 shares of the company’s stock after selling 45,544 shares during the period. Schroder Investment Management Group owned approximately 0.60% of Altimmune worth […] - 2025-04-06 08:34:53
Nichole Stella Buys 50,000 Shares of Altitude Group plc (LON:ALT) Stock: Altitude Group plc (LON:ALT – Get Free Report) insider Nichole Stella purchased 50,000 shares of the business’s stock in a transaction on Monday, March 31st. The shares were bought at an average price of GBX 26 ($0.34) per share, for a total transaction of £13,000 ($16,880.92). Altitude Group Stock Performance ALT opened at GBX 25.25 […] - 2025-04-03 05:24:59
Sequoia Financial Advisors LLC Acquires 3,500 Shares of Altimmune, Inc. (NASDAQ:ALT): Sequoia Financial Advisors LLC grew its stake in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) by 34.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 13,655 shares of the company’s stock after purchasing an additional 3,500 shares during the period. Sequoia Financial Advisors LLC’s holdings […] - 2025-03-21 08:24:59
Noteworthy Friday Option Activity: DXC, ALT, MSFT: Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in DXC Technology Co (Symbol: DXC), where a total volume of 15,294 contracts has been traded thus far today, a contract volume which is representative of approximat - 2025-03-14 19:20:35
Rhumbline Advisers Has $756,000 Stake in Altimmune, Inc. (NASDAQ:ALT): Rhumbline Advisers lowered its stake in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 4.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,876 shares of the company’s stock after selling 4,343 shares during the quarter. Rhumbline Advisers’ holdings in Altimmune were worth […] - 2025-03-07 09:22:50
Altimmune, Inc. (NASDAQ:ALT) Stock Position Decreased by Los Angeles Capital Management LLC: Los Angeles Capital Management LLC cut its stake in shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) by 53.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,197 shares of the company’s stock after selling 35,340 shares during the period. Los Angeles Capital Management […] - 2025-03-05 10:41:41
Altimmune (NASDAQ:ALT) Given “Buy” Rating at HC Wainwright: Altimmune (NASDAQ:ALT – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They presently have a $12.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 101.34% from the stock’s previous close. A number of other research […] - 2025-03-05 06:56:51
Altimmune, Inc. (NASDAQ:ALT) Sees Large Decline in Short Interest: Altimmune, Inc. (NASDAQ:ALT – Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 23,320,000 shares, a decrease of 5.2% from the January 15th total of 24,590,000 shares. Based on an average daily trading volume, of 3,190,000 shares, the short-interest ratio is currently 7.3 […] - 2025-02-19 08:46:12
Brokerages Set Altimmune, Inc. (NASDAQ:ALT) Price Target at $20.83: Altimmune, Inc. (NASDAQ:ALT – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. […] - 2025-02-04 06:46:59

ALT institutional holdings

The following institutional investment holdings of ALT have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 36,627 USD 212,437 7.6%

2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 36,015 USD 208,887

2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 36,015 USD 208,887 7.6%

2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,195 USD 6,931

Total = 109,852 USD 637,142
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	36,627	USD 212,437 7.6%
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	36,015	USD 208,887
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	36,015	USD 208,887 7.6%
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,195	USD 6,931
Total =	109,852	USD 637,142

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.